Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for assessment of progressive decline in kidney function. This tool will be launched as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback